PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Status:
Completed
Trial end date:
2017-02-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether apremilast is safe and effective in the
treatment of patients with psoriatic arthritis and a qualifying psoriasis lesion.
Apremilast is proposed to improve signs and symptoms of psoriatic arthritis (tender and
swollen joints, pain, physical function) in treated patients.